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Background and Purpose: The difficulty in the treat-
ment of severe open fractures is a high infection rate 
and the problem of an adequate temporary cover-
age of the soft-tissue damage between successive 
second-look operations. The vacuum-assisted closure 
(V.A.C.®) offers good temporary soft-tissue coverage 
with a proven bacterial clearance and protects, at the 
same time, the soft tissue against secondary damage. 
The retrospective study reports the soft-tissue man-
agement of severe open fractures of Gustilo type IIIA 
and IIIB with V.A.C.® or Epigard®.
Patients and Methods: All open fractures were in the 
lower extremity and a result of a nonpenetrating trau-
ma. V.A.C.® was used as a temporary dressing in 
14 fractures and an Epigard® in twelve fractures.
Results: One early amputation was observed in each 
group. In the group with the soft-tissue coverage by 
Epigard®, in spite of less type IIIB fractures and less 
polytraumatized patients, the rate of infections (6/11) 
was substantially higher compared with patients man-
aged by V.A.C.® therapy (infection: 2/13).
Conclusion: V.A.C.®, a temporary soft-tissue substitute, 
reduces the rate of infection and is an alternative of 
choice for the management of type III open fractures.
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Introduction
The management of high-energy open fractures contin-
ues to be a difficult problem confronting the surgeon. 
The essential part of an initial soft-tissue damage treat-
ment is copious irrigation and thorough debridement [1, 
2], which can cause significant soft-tissue defects. Then 
it must be decided whether the wound should be closed 
primarily or left open for delayed suture or reconstruc-
tive surgery. Different surgical methods have been de-
veloped to perform these difficult closures or temporary 
coverage. These include closure devices [3], skin grafts, 
local flaps, and free flap transfers. It was recommended 
to carry out the definitive soft-tissue coverage as soon 
as possible, preferably within the first 72 h after trauma 
[4], by a delayed primary closure of the wound [5] to 
prevent flap failures, infection and delayed bone heal-
ing. This, however, is often impracticable because of a 
complicated fracture, wound contamination or already 
existent infection or the associated injuries accompa-
nied by hemodynamic instability and microcirculatory 
dysfunctions based on systemic inflammation or edema 
[6, 7] which prevent an early long-lasting reconstructive 
surgical intervention. Although skin grafts are readily 
obtainable, they depend on the vascularity of the recipi-
ent bed and may be contraindicated by exposed bone, 
cartilage, tendons or surgical implants. Consequently, 
one or more “second-look” operations are neces-
sary prior to the definitive closure and an appropriate 
wound dressing is needed as a temporary coverage be-
tween repeated debridements. The essential request for 
such a temporary closure is to prevent the exposed vital 
structures from desiccation and bacterial contamina-
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tion and to induce a locally normal circulatory situation 
and proliferation of the wound granulation tissue. The 
traditional dressings for open wounds are wet-to-dry 
closures [1, 2, 8–17], antibiotic-impregnated bead pouch 
[18] and skin substitutes including xenografts, human 
allografts or synthetic membranes such as, Epigard® 
(Biovision GmbH, Ilmenau, Germany) [19–23]. The 
vacuum-assisted closure (V.A.C.®, Kinetic Concepts, 
Inc., San Antonio, TX, USA), a new, efficient system 
for the treatment of problematic wounds [24–29], be-
came a generally accepted technique and was applied 
as a temporary wound closure also in the case of open 
fractures [30–32]. Epigard® treatment was the standard 
dressing for soft-tissue management in our clinic until 
the late 1990s. Since 2000 it was substituted stepwise by 
V.A.C.®, which finally became the standard temporary 
closure of problematic wounds of various types. The 
purpose of this case control report is to compare ret-
rospectively two standard techniques of a temporary 
wound coverage and to evaluate the results of the use 
of these therapies in the management of patients with 
high-energy soft-tissue injuries of Gustilo type III open 
fractures [2] of lower extremities.
Patients and Methods
All patients had severe open fractures of the lower 
extremity classified as type IIIA or IIIB according to 
Gustilo et al. [2] and were admitted as an emergency 
to our clinic. In this study we excluded all type IIIC 
fractures because of the associated vascular injuries, 
which compromise the circulatory situation of the local 
soft-tissue injury. The patients not included in the study 
were treated during the interim when we stepwise intro-
duced V.A.C.®, and both techniques were used simul-
taneously and partly consecutively in the same patient. 
All fractures were a result of a high-energy trauma, and 
the partly polytraumatized patients were treated ac-
cording to the Advanced Trauma Life Support Guide-
lines [33] and our standard trauma protocol [34, 35]. Af-
ter control of the airway, ventilation and cardiovascular 
functions, life-saving procedures were performed. Af-
terwards, hemorrhage control, radical wound debride-
ment, decompression of compartments, and primary 
stabilization of major fractures (“day 1 surgery”) were 
carried out [34, 35]. Debridement of open fractures was 
performed in a stepwise manner, i.e., one debridement 
in the emergency room and two further debridements 
with copious irrigation in the operating room on the ad-
mission day, and primary immobilization of the fracture 
was carried out preferably by external skeletal fixation. 
“Second-look” operations included subsequent thor-
ough debridements, fracture redislocation and repeated 
irrigation with normal saline solution and were carried 
out, as far as possible, every 48 h in dependence of the 
wound and patients condition. The V.A.C.® system or 
Epigard® was applied at the end of each surgical second 
look. This procedure was repeated until the soft-tissue 
defect became macroscopically clean and was free of 
necrotic tissue.
The V.A.C.® system was applied in a group of 
twelve patients with 14 open fractures treated between 
June 2001 and December 2002 (group I). The V.A.C.® 
system consists of polyurethane soft sponge shaped to 
fit the wound and placed into the cavity. The 400–600 
mm pore size of the sponge maximizes tissue growth 
[36]. The suction tube with side ports was embedded in 
the center of the sponge allowing communication of its 
lumen to all spaces of the foam and attached to an ad-
justable suction pump. A transparent occlusive gas- and 
fluid-impermeable plastic film was applied over the 
foam to seal it airtight and the pump was started to pro-
duce a continuous negative pressure of 125 mmHg.
A group of eleven patients with twelve open frac-
tures, hospitalized between March 1998 and November 
1999, was treated with Epigard® as the temporary closure 
(group II). Epigard® dressing, reticulated polyurethane 
foam laminated to a microporous polypropylene film, 
is applied in a manner similar to skin grafting, i.e., it is 
stapled to the wound edges and afterwards covered with 
a sterile dressing. Both groups of our patients belong to 
time periods when Epigard® and V.A.C.®, respectively, 
were used as a standard technique. The dressing change 
in both groups was performed under general anesthe-
sia during each “second look” in the operating room. 
Bacterial cultures were obtained routinely on admission 
and during each “second look”. A cephalosporin of the 
third generation was systemically applied in therapeu-
tic doses on admission and continued or adapted to the 
bacterial culture results.
Clinical data in Table 1 include the study population, 
the cause of the injury, the Injury Severity Score (ISS) 
[37], associated injuries, and hospital and intensive care 
unit (ICU) stay. Fracture localization, classification ac-
cording to Gustilo et al. [2] and Mangled Extremity Se-
verity Score (MESS) [38–40] are summarized in Table 
2. Evaluation of both techniques includes the duration 
of the temporary coverage use, the final wound closure 
type and its outcome, and the fracture management and 
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its complications (Table 2). Bacterial characteristics and 
soft-tissue complications are summarized in Table 3. All 
patients were followed for a minimum of 12 months af-
ter definitive soft-tissue coverage to verify healing or 
complications.
Results
The temporary wound closure changes averaged 4.3 in 
group I (range 1–10) and 2.2 in group II (range 1–3). 
Epigard® was used for a total of 4.9 days on average 
(range 2–9 days), whereas V.A.C.® covered the wound 
for 11.3 days (range 2–35 days). Figure 1 shows a severe 
soft-tissue defect of IIIB fracture with luxation of the 
right ankle (patient #2), which was temporarily closed by 
V.A.C.®. Only four wounds out of both groups (group I: 
patient #9; group II: patients #7, 8, and 10) did not need 
any further treatment, and the delayed primary clo-
sure could be directly performed. All other soft-tissue 
defects were covered mostly by microvascular flaps or 
mesh grafts (Table 2). The clinical result of a type IIIB 
fracture (patient #2) after soft-tissue reconstruction 
with microvascular flap is shown in Figure 2. Soft-tissue 
reconstruction was performed after an average of 12.3 
days in group I (range 2–35 days) and 4.1 days (range 
2–8 days) in group II. An amputation in group I had to 
be performed 10 days after admission (patient #5) due 
to complete necrosis of the soft tissues of the foot. We 
had two serious soft-tissue complications in group I with 
infections (patients #6 and 11) resulting in a nonunion 
situation of the bone (one intraarticular fracture of the 
distal femur and one tibial shaft fracture) where the 
soft-tissue defect was closed by a microvascular flap 12 
and 5 days after trauma, respectively. In both cases the 
plate implants were removed and a debridement of the 
soft tissue and of the nonhealing fracture was performed. 
Both fractures were stabilized by plates and bone graft-
ing from iliac crest. Both fractures consolidated after 6 
and 4 months, respectively. One minor complication, 
also in group I, with an infection in the former bed of the 
microvascular flap used for reconstruction of the tibial 
soft-tissue defect occurred in patient #8. After debride-
ment the wound healed uneventfully without any signs 
of infection. In group II, six complications were severe 
soft-tissue infections, combined with a nonunion in two 
cases, and one complication was a nonunion without in-
fection (Tables 2 and 3). In three patients (#1, 2, and 6) 
Table 1. Clinical characteristics of patients. a: head; b: thorax; c: abdomen; d: extremities: e: skin; F: female; ICU: intensive care unit; ISS: Injury Se-
verity Score [37]; M: male.
 Patient Gender Age Cause of injury  Multiply injured Associated Hospital  ICU stay  
   (years)   Traffic Impaction Fall from height (ISS) injury stay (days) (days) 
Group I   1 M 56  +  No    17  – 
(V.A.C.®)   2 F 64   + Yes (41) a, b, c, d, e   61 15    
    3 F 18   + Yes (41) a, b, c, d, e   32 32    
    4 F 45 +   No    34  –    
    5 M 56 +   Yes (34) a, b, c, d, e   67 37    
    6 M 22 +   Yes (57) a, b, c, d 158 27    
    7 M 19 +   Yes (19) a, b, d   37 10    
    8 M 54  +  Yes (34) a, b, d, e   63 27    
    9 M 33  +  No    30  –    
  10 F 68 +   Yes (34) c, d, e   62 20    
  11 M 31  +  No    35  –    
  12 M 35   + Yes (34) b, c, d, e   43   5    
              
Group II    1 F 30 +   No b, d   29   6    
(Epigard®)   2 M 43   + No    27     
    3 M 75 +   No    38   –    
    4 M 40   + No    41   2    
    5 F 89 +   Yes (20) d, e   95   –    
    6 M 62 +   No    35   –    
    7 M 20  +  No    25   –    
    8 F 43 +   Yes (18) b, d   21   –    
    9 M 49  +  No    20   –    
  10 M 49   + No    27   –    
  11 M 46 +   Yes (38) b, c, d, e 104 48
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the soft-tissue injury was closed by a microvascular flap 
and in two patients (#8 and 10) by a delayed primary 
closure. The free flap reconstructions were performed 
on the 2nd, 3rd and 7th day and the delayed primary 
closures on the 4th and 8th day after admission. An am-
putation had to be performed 5 days after admission on 
the sixth patient (#5) due to an uncontrollable infection 
situation. The patient died 2 days afterwards due to car-
diovascular instability. The three observed nonunions 
of tibial fractures in group II were caused by a local in-
fection 43 and 125 days after trauma in two cases, and in 
one case the nonunion was seen after 75 days. The local 
infection of the tibial fracture in patient #1 resulted in a 
septic complication of the uncontrollable infection un-
der the free flap, and as a consequence, an amputation 
was necessary on the 8th day. Of the remaining five pa-
tients, four (#2, 6, 8, and 10) had a debridement 43, 157, 
33, and 125 days after trauma with loss of the primary 
free flap in two cases (#2 and 10) and replacement by a 
soleus flap. Implants were removed in three patients (#2, 
6, and 10) during debridement. In patient #6 the frac-
ture consolidated. After reaming, a new intramedullary 
nail was used in patient #2, and the tibial nonunion was 
treated by a new plate and a bone graft from iliac crest 
in patient #10. Both tibial fractures healed 4 months 
later. After treatment of the local infection, the fracture 
of patient #8 healed uneventfully after 5 months. In pa-
tient #9 the nonunion situation after bone debridement 
was treated by a bone graft from the iliac crest and the 
fracture consolidated after 12 weeks. All seven serious 
Table 2. Open fracture pattern. MESS: Mangled Extremity Severity Score [38–40].
 Patient Injury pattern and fracture classification Fracture management  Soft-tissue manage- Compli-
  Localization   Gustilo     ment    cations
       classification MESS Primary  Secondary  Definitive 
          stabilization stabilization stabilization
          (admission day)  (days after 
            admission)
  
Group I   1       +     + 5 External fixator Plate   5    +      
(V.A.C.®)   2       +     + 7 External fixator Plate   6    +      
    3      +   + 4 External fixator –   –    +      
    4       +     + 4 External fixator Plate   3    +      
    5      +   + 5 External fixator – 10     +
        +     + 7 External fixator K-wire  2   +
    6    +      + 5 External fixator Plate   6    +    +
     +      + 5 External fixator Screw   6   +
    7      +   + 2 External fixator Screw   7    +      
    8       +     + 6 External fixator Plate 18    +      
    9      + +  4 External fixator –   –     +        
  10       +     + 6 External fixator Plate 12    +      
  11       +     + 3 External fixator Plate   5    +    +
  12  +     +  3 Plate –   –   +       
Group II    1       +     + 5 Plate –   –    +  +     
(Epigard®)   2       +   +  2 External fixator Nail   3    +    +
    3       +   +  4 Plate –   –    +      
    4       +   +  3 Plate –   –    +      
    5       +     + 5 External fixator –   –     +     
    6       +     + 4 External fixator Plate   7    +      
    7  +       + 4 External fixator Plate   5     +        
    8       +     + 6 External fixator Plate   9     +        
    9       +     + 3 Nail –   –    +    +
  10       +   +  3 External fixator Plate   8     +      +
 11  +       + 9 External fixator Plate   2   +
     +      + 5 External fixator Cerclage   2    +
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Table 3. Bacteriologic characteristics of soft-tissue defects. No: no bacterial growth; SKN: Staphylococcus coagulase-negative.
 Patient Wound contam- Primary antibiotic Change of antibiotic  Wound infec- Bacteriologic species
  ination on  therapy during hospital tion in of infected wounds
  admission   stay follow-up (days)      
Group I    1 SKN, Brevibacterium spp. Cephalosporin –      
(V.A.C.®)   2 Bacillus cereus β-lactam antibiotica Vancomycin, β-lactam antibiotic      
    3 Bacillus cereus Cephalosporin Vancomycin, cephalosporin      
    4 No Cephalosporin –      
    5 Bacillus cereus,  Cephalosporin Teicoplanin, ciprofloxacin
  Staphylococcus aureus
    6 Bacillus cereus, SKN Cephalosporin Vancomycin, ciprofloxacin,  112 SKN  
    rifampicin  
    7 Bacillus cereus Cephalosporin Clindamycin      
    8 No Cephalosporin Cephalosporin, β-lactam antibiotic      
    9 SKN Cephalosporin –      
  10 SKN Cephalosporin Ciprofloxacin      
  11 No Cephalosporin Rifampicin, aminopenicillin 211 β-hemolytic 
      Streptococcus group A
  12 Bacillus cereus Cephalosporin –
           
Group II    1 Staphylococcus aureus,  Cephalosporin –     8 Staphylococcus aureus,
(Epigard®)  SKN    SKN    
   2 No Cephalosporin –   43 Staphylococcus aureus   
    3 Bacillus cereus Cephalosporin Ciprofloxacin, rifampicin      
    4 Bacillus cereus, SKN Cephalosporin Vancomycin, ciprofloxacin, rifampicin      
    5 Bacillus cereus Cephalosporin Vancomycin, cephalosporin     5 Bacillus cereus    
    6 SKN, Pseudomonas Cephalosporin Vancomycin, cephalosporin 157 Staphylococcus aureus
    7 No Cephalosporin –      
    8 Bacillus cereus Cephalosporin Ciprofloxacin, rifampicin   33 Pseudomonas    
    9 SKN Cephalosporin Ciprofloxacin      
  10 SKN Cephalosporin Ciprofloxacin 125 Staphylococcus aureus
  11 Bacillus spp. Cephalosporin –    
aMeronem® used because of severe lung injury
Figures 1a and 1b. a) Severe soft-tissue defect of a IIIB fracture with luxation of the right ankle (patient #2). b) External fixation of the right ankle 
and coverage of soft-tissue defect by V.A.C.® after debridement of the soft tissue and fracture.
a b
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complications in group II occurred 
in seven out of nine tibial fractures, 
whereas in group I only one of seven 
tibial fractures was involved in bac-
terial infection (Tables 2 and 3). The 
MESS of the tibal fractures averaged 
5.4 in group I (range 3–7) and 4.1 in 
group II (range 2–7).
All wounds except three ampu-
tations (group I: patient #5; group 
II: patients #1 and 5) were available 
for follow-up examination. During 
follow-up, local soft tissue healed 
uneventfully in 11/13 and 5/10 lower 
extremities in groups I and II, respec-
tively.
Discussion
Severe soft-tissue damage, wound 
contamination, compromised vascu-
larity, and fracture instability are the 
four factors determining the outcome 
of severe type III open fractures and 
are predictive of later complications 
[2]. The fracture location and its con-
figuration are of less importance [2]. 
The main obstacle always is the man-
agement of the wound injury, and the 
bone mostly is not a problem when 
the soft tissue is in order [41]. The 
studies dealing with the management 
of open fractures and their delayed 
definitive stabilization concentrate 
on skeletal fixation and definitive 
wound closure. The problem of the 
open wound mostly is not discussed 
in detail. In our study, we concen-
trated on the healing process of the 
wound before a definitive closure 
and on the temporary wound dress-
ing. The definitive wound closure 
as well as the skeletal location and 
stabilization are not the topic of this 
study and are listed in Table 2.
The V.A.C.® management has 
not yet been compared with any 
of the classic methods of temporary closure of open 
fractures except one case report where poor results 
of a wet-to-dry dressing were fairly improved by a 
successful V.A.C.® application [32]. Although the 
number of our patients is small for firm conclusions 
to be reached, a drawback of all studies reporting 
Figures 2a to 2d. a, b) Clinical result of the type IIIB fracture of Figure 1 after soft-tissue recon-
struction with a microvascular flap. c, d) X-rays of the IIIB fracture 8 months after trauma with 
documented bone healing.
a b
c d
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open fractures of lower extremities with 16 patients 
at best [30–32, 42–44], we believe that there is still a 
higher tendency to an infection when Epigard® is ap-
plied. This follows not only from a lower infection 
rate in group I (Table 2), but also from the fact that 
the group in question includes more IIIB fractures, 
more severely injured patients (ISS > 17) with SIRS 
(systemic inflammatory response syndrome) accom-
panied with immune deficiency and requiring some-
times a multitude of dressing changes with sur gical 
debridements in the operating room before defini-
tive soft-tissue reconstruction. This also is due to the 
fact that in many of the severely injured patients (ISS 
> 17) in group I, the reconstructive surgery by free flap 
could be performed only when the patients were under 
stable conditions and this exceeded mostly the time 
recommended for an early covering of soft-tissue de-
fects in open fractures [4, 5]. The nearly twofold num-
ber of surgical debridements in group I, compared with 
group II, might be responsible for the lower infection 
rate in the follow-up [45]. This as well might explain 
that one infection only was observed, and that in the 
case of debridement after the shortest time of 5 days 
in group I, where the wounds were generally covered 
later by a surgical intervention after 6.9 days on aver-
age, in comparison with group II where the interven-
tion was carried out earlier after 4.4 days and the num-
ber of infections was higher. The low infection rate of 
the V.A.C.® system corresponds with the results in the 
literature [30–32, 42, 43]. The MESS values of ≥ 4 are 
sensitive and indicate an amputation [40], and in this 
connection it is worth mentioning that no amputations 
were necessary in the tibial fractures of group I despite 
MESS values of 5.4 (Table 2). In group II, on the other 
hand, two amputations in this fracture localization by 
values of 4.1 had to be carried out as a consequence of 
an uncontrollable infection situation.
Although the difference between both groups is not 
statistically significant and a striking proof could not 
yet be supplied, important properties of V.A.C.®, miss-
ing in the Epigard® system, speak in favor of the for-
mer one. The negative pressure continuously removes 
the interstitial fluid from the wound together with the 
factors suppressing the proliferation of keratinocytes, 
fibroblasts and vascular endothelial cells. This simulta-
neously improves the capillary blood flow and produces 
a rapid formation of granulation tissue. The bacterial 
colonization is substantially reduced after few days. The 
dressing completely isolates the wound and decreases 
a secondary contamination from the environment. The 
mechanical pressure seems to promote cell mitosis and 
new blood vessel formation and the suction draws the 
wound edges slowly together.
Conclusion
In spite of the small number of patients, the results show 
the efficiency of the V.A.C.® system, and its use in the 
wound care of severe open fractures can be recom-
mended as an alternative to Epigard®.
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